Nav: Home

Novel approach keeps liquids from freezing at very low temperatures for extended periods

August 10, 2018

Investigators from the Massachusetts General Hospital Center for Engineering in Medicine (MGH-CEM) have developed a simple method to maintain water and water-based solutions in a liquid state at temperatures far below the usual "freezing point" for greatly extended periods of time. While they currently have accomplished this for volumes of only a few ounces, their approach - described in the journal Nature Communications - may someday enable safe, extended preservation of blood cells, tissues and organs, along with improved food preservation.

"Water and other aqueous solutions in the sorts of volumes we deal with every day normally freeze when cooled below the freezing point of 0° C or 32° F," says O. Berk Usta, PhD, of the MGH-CEM, co-corresponding author of the report. "Our approach, which we dubbed 'deep supercooling,' is simply to cover the surface of such a liquid with a solution that does not mix with water, like mineral oil, to block the interface between water and air, which is the major site of crystallization. This surprisingly simple, practical and low-cost approach to supercooling solutions for extended periods can enable many medical and food preservation methods, as well as fundamental experiments that were not previously possible."

In most real-world environments, water and water-based solutions begin to freeze when the temperature reaches below 0° C/32° F, with ice crystals randomly forming where the liquids contact air or various impurities in the solution. Supercooling - reducing a liquid below its usual freezing point without crystallization - has been achieved for very small volumes and brief periods of time or by using high pressure equipment that is both costly and possibly damaging to tissues or other biological materials.

Reducing the temperature of any biological material - such as cold storage of perishable foods and organs for transplantation - slows down metabolic and other reactions. Supercooling extends this metabolic deceleration further without the damage caused by ice crystallization. Following upon observations by lead author Haishui Huang, PhD, the team first found that sealing the surface of a small (1 ml) water sample with a hydrocarbon-based oil - such as mineral oil, olive oil or paraffin oil - could suppress ice formation at temperatures as low as -13° C (around 9° F) for up to a week. Through a series of experiments both with more complex oils and with pure simple hydrocarbons, such as alcohols and alkanes, they succeeded in keeping 1 ml samples of water and cell suspensions supercooled at -20° C (-4° F) for 100 days and 100 ml (3.2 oz) samples for a week.

The team also demonstrated application of their deep supercooling method to the extended preservation of red blood cells. While red blood cells are usually stored at 4° C (39° F) for as long as 42 days, recent reports have suggested that cell quality at that temperature begins to decline after around 14 days, and irreversible cellular injury sets in after 28 days, challenging current blood banking practice. The MGH-CEM team's preliminary experiments indicated that their deep supercooling approach could safely preserve red-blood-cell suspensions of up to 100 ml at -13° C for as long as 100 days, more than doubling the current storage time.

"We currently are conducting experiments to increase the volume of red blood cell storage samples up to the more clinically relevant 300 to 500 ml range," says Usta, who is an assistant professor of Surgery at Harvard Medical School. "We also are working on applying this method to other cells and on translating it to large tissues and whole organs like the liver. Along with potential applications in medicine and food preservation, we also believe this invention could be used to study chemical reactions in the liquid state at low temperatures without the usual costly and complicated high-pressure equipment."
-end-
Martin Yarmush, MD, PhD, director of the MGH-CEM is co-corresponding author of the Nature Communications report. The study was supported through National Institutes of Health grants 5P41 EB002503, 1R21 EB020192 and 5R01 EB023812. The MGH has filed a patent application covering this work.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $900 million and major research centers in HIV/AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, genomic medicine, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, photomedicine and transplantation biology. The MGH topped the 2015 Nature Index list of health care organizations publishing in leading scientific journals and earned the prestigious 2015 Foster G. McGaw Prize for Excellence in Community Service. In August 2017 the MGH was once again named to the Honor Roll in the U.S. News & World Report list of "America's Best Hospitals."

Massachusetts General Hospital

Related Red Blood Cells Articles:

Natural resistance to malaria linked to variation in human red blood cell receptors
Researchers have discovered that protection from the most severe form of malaria is linked with natural variation in human red blood cell genes.
Researchers use modified insulin and red blood cells to regulate blood sugar
Researchers have developed a new technique that uses modified insulin and red blood cells to create a glucose-responsive 'smart' insulin delivery system.
Resilient red blood cells need fuel to adapt their shape to the environment
An international research team led by Osaka University built a novel 'Catch-Load-Launch' microfluidic device to monitor the resilience of red blood cells after being held in a narrow channel for various periods of time.
Major breakthrough in the manufacture of red blood cells
Researchers have generated the first immortalized cell lines which allow more efficient manufacture of red blood cells.
Cargo-carrying red blood cells alleviate autoimmune diseases in mice
Using red blood cells modified to carry disease-specific antigens, a team of scientists from Whitehead Institute and Boston Children's Hospital have prevented and alleviated two autoimmune diseases -- multiple sclerosis (MS) and type 1 diabetes --i n early stage mouse models.
UNC-Chapel Hill researchers use light to launch drugs from red blood cells
Scientists at the University of North Carolina at Chapel Hill have developed a breakthrough technique that uses light to activate a drug stored in circulating red blood cells so that it is released exactly when and where it is needed.
Andeans with altitude sickness produce massive amounts of red blood cells
To better understand why some people adapt well to life at high altitude while others don't, researchers at University of California San Diego School of Medicine studied red blood cells derived from representatives of both groups living in the Andes Mountains.
Pretreating red blood cells with nitric oxide may reduce side effect linked to transfusions
A new treatment may diminish a dangerous side effect associated with transfusions of red blood cells (RBCs) known as pulmonary hypertension, an elevated blood pressure in the lungs and heart that can lead to heart failure, suggests a new study published in the November issue of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists (ASA).
Expert panel issues updated guidelines for red blood cell storage time and transfusion use
For most stable hospitalized patients, transfusions of red blood cells stored for any time point within their licensed dating period -- so-called standard issue -- are as safe as transfusions with blood stored 10 days or less, or 'fresh,' according to updated clinical guidelines issued by an expert panel convened by a national organization that has long set standards for blood banking and transfusion practices.
Updated AABB guidelines for when to perform red blood cell transfusion, optimal length of RBC storage
In a report published online by JAMA, Jeffrey L. Carson, M.D., of Rutgers Robert Wood Johnson Medical School, New Brunswick, N.J., and colleagues provide recommendations for the AABB (previously known as the American Association of Blood Banks) for the target hemoglobin level for red blood cell (RBC) transfusion among hospitalized adult patients who are hemodynamically stable and the length of time RBCs should be stored prior to transfusion.

Related Red Blood Cells Reading:

A Simple Guide To Red Blood Cells, Functions, Diseases, Diagnosis, Treatment, And Related Conditions

Red and White Blood Cells! What, How and Why of Human Cells - Body Chemistry Edition - Children's Clinical Chemistry Books
by Pfiffikus (Author)

Focus On: 80 Most Popular Human Cells: List of distinct cell types in the adult human Body, Red blood Cell, Neutrophil, T Cell, Platelet, Macrophage, Monocyte, B Cell, T helper Cell, Mast Cell, etc.
by Focus On

Journal Pages - Red Blood Cell: 6" x 9", lined journal, blank book notebook, durable cover,150 pages for writing
by Journal Pages (Author), Blank Lined Journal (Author)

The Born-Again Diabetic: The Handbook to Help You Get Your Diabetes in Control (Again)
by Red Blood Cell Books

Beyond Fingersticks: The Art of Control with Continuous Glucose Monitoring
by Red Blood Cell Books

Red Blood Cell Aggregation
by CRC Press

Taming the Tiger: Your First Year with Diabetes
by Red Blood Cell Books

Phosky and Reedox: Life As a Human Red Blood Cell
by Lulu.com

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Circular
We're told if the economy is growing, and if we keep producing, that's a good thing. But at what cost? This hour, TED speakers explore circular systems that regenerate and re-use what we already have. Guests include economist Kate Raworth, environmental activist Tristram Stuart, landscape architect Kate Orff, entrepreneur David Katz, and graphic designer Jessi Arrington.
Now Playing: Science for the People

#503 Postpartum Blues (Rebroadcast)
When a woman gives birth, it seems like everyone wants to know how the baby is doing. What does it weigh? Is it breathing right? Did it cry? But it turns out that, in the United States, we're not doing to great at asking how the mom, who just pushed something the size of a pot roast out of something the size of a Cheerio, is doing. This week we talk to anthropologist Kate Clancy about her postpartum experience and how it is becoming distressingly common, and we speak with Julie Wiebe about prolapse, what it is and how it's...